HomeTechnology

Technology

Uncategorized

Base to Base biotech podcast 75: AI-powered diagnostics and cancer immunotherapy

Jim Cornall - September 11, 2026

biotech

Is atherosclerosis an autoimmune disease?

Jim Cornall - September 10, 2026

biotech

Northway Biotech opens €61m cell therapy and personalised medicine CDMO in Lithuania

Jim Cornall - September 10, 2026

biotech

Eascra Biotech receives NASA contract for space-manufactured nanomedicine

Jim Cornall - September 10, 2026

Technology

Could satellites+5G=3bn new internet users?

Jim Cornall - April 3, 2025

Technology

Nasscom hosts inaugural Global Confluence 2025

Jim Cornall - March 25, 2025

Technology

India looks to grow deeptech with technology parks

Jim Cornall - March 20, 2025

Technology

Gilat investing in drone detection startup Crosense

admin - March 5, 2025

Technology

Fonon Technologies to bring laser tech to NCMS Sustainment Accelerator in Japan

Jim Cornall - February 20, 2025

Technology

Advancement in real-time 3D localization for first responders

Jim Cornall - January 15, 2025

Technology

Opportunities unleashed by chiplet technology: A new era for the semiconductor industry

admin - January 9, 2025

AI

Perciv AI secures €2.5m to expand radar solutions

Jim Cornall - December 23, 2024

123...8 Page 2 of 8

Stay Connected

- Advertisement -

spot_img

Latest Articles

Uncategorized

Base to Base biotech podcast 75: AI-powered diagnostics and cancer immunotherapy

Jim Cornall - September 11, 2026 0

This week, we talk to a company in Lund, Asgard Therapeutics, and its co-founder and CEO Cristiana Pires, about in vivo direct cell reprogramming...

Is atherosclerosis an autoimmune disease?

biotech Jim Cornall - September 10, 2026 0

Northway Biotech opens €61m cell therapy and personalised medicine CDMO in Lithuania

biotech Jim Cornall - September 10, 2026 0

Eascra Biotech receives NASA contract for space-manufactured nanomedicine

biotech Jim Cornall - September 10, 2026 0

Typewriter Therapeutics emerges from stealth with $56m to pursue in vivo CAR T medicines

biotech Jim Cornall - September 9, 2026 0